STAT

Silicon Valley’s ambitious new bet: Brain ‘modems’ that restore sight, hearing, and speech

Paradromics is one of several Silicon Valley companies developing brain-machine interfaces to replace senses and abilities lost to disease and injury.

SAN JOSE, Calif. — In a warehouse district here, a few young engineers fueled by ramen and energy bars are inventing the future of mind reading.

Paradromics has big ambitions: It wants to squeeze a device the size of a mobile phone into a chip small enough to insert into a human brain, where it would “read” nerve signals and replace senses and abilities lost due to injury or diseases.

For now, the startup’s recently minted Ph.D.s are working in a small warren of scruffy offices and labs to perfect a stuffed-mouse mockup. You’d never guess that it won an $18 million Pentagon contract last month, vaulting it into the top ranks of Silicon Valley companies surging into the field of brain-machine interfaces.

It joins such titans as Facebook and Tesla’s Elon Musk, and the valley’s growing interest in neuroscience has generated considerable excitement that brain interface products will some day let the blind see, the deaf hear, and patients with ALS speak — Paradromics’s initial focus. But these are early days, and there are huge technical challenges ahead, as well as safety, privacy, and ethical considerations facing tech companies not used to

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.

Related Books & Audiobooks